75F40124F19001↗
Booz Allen Hamilton Inc received this contract from Fda Office of Acq Grant Svcs, Food and Drug Administration: $176.4K obligated so far for support- management: other. Its period of performance ended 2025-04-08.
Key facts · data as of Oct 26, 2026
- Recipient
- Booz Allen Hamilton Inc
- Awarding agency
- Food and Drug Administration (Department of Health and Human Services)
- Contracting office
- Fda Office of Acq Grant Svcs (75F401)
- Obligated to date
- $176.4K
- Potential value
- $176.4K
- Ends
- 2025-04-08
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.
Cite this page: SpendQuery, Award 75F40124F19001, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_AWD_75F40124F19001_7524_75F40124A00001_7524
Booz Allen Hamilton Inc: all federal awards · Department of Health and Human Services: spending · Fda Office of Acq Grant Svcs: what it buys
THE OBJECTIVE OF THIS BPA IS TO PROCURE TECHNICAL AND MANAGEMENT CONSULTING SERVICES TO COMPREHENSIVELY SUPPORT THE PLANNING FOR AND IMPROVEMENTS IN BUSINESS OPERATIONS ACROSS THE FDA ENTERPRISE.
What it is
- Product or service
- Support- Management: Other (PSC R799)
- Industry
- Administrative Management and General Management Consulting Services (NAICS 541611)
- Contracting office
- Fda Office of Acq Grant Svcs (75F401)
- Competition
- Full and open competition
- Pricing
- Firm fixed price
- How it was bought
- Blanket purchase agreement (BPA) · under 75F40124A00001
- Where the work is
- Fairfax, VA · district VA-11
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
5 actions since 2024-07-11. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-08-05 | P00004 | Close-out | -$0 | THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FUNDS AND CLOSE OUT THE CONTRACT. |
| 2025-12-09 | P00003 | Supplemental agreement (work within scope) | -$175.9K | TERMINATION SETTLEMENT FOR THE FULL TERMINATION FOR THE CONVENIENCE OF THE GOVERNMENT UNDER P00002 |
| 2025-04-08 | P00002 | Terminated for convenience | $0 | EOI:: GSA WASTEFUL SPENDING ::EOI FULL TERMINATION FOR CONVENIENCE |
| 2024-11-07 | P00001 | Administrative change | $0 | THE OBJECTIVE OF THIS BPA IS TO PROCURE TECHNICAL AND MANAGEMENT CONSULTING SERVICES TO COMPREHENSIVELY SUPPORT THE PLANNING FOR AND IMPROVEMENTS IN BUSINESS OPERATIONS ACROSS THE FDA ENTERPRISE. |
| 2024-07-11 | 0 | $352.2K | THE OBJECTIVE OF THIS BPA IS TO PROCURE TECHNICAL AND MANAGEMENT CONSULTING SERVICES TO COMPREHENSIVELY SUPPORT THE PLANNING FOR AND IMPROVEMENTS IN BUSINESS OPERATIONS ACROSS THE FDA ENTERPRISE. |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗